Status:
COMPLETED
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Stress Disorder, Post Traumatic
Eligibility:
All Genders
21-65 years
Phase:
PHASE2
PHASE3
Brief Summary
This study will determine whether a combination of virtual reality exposure therapy and D-cycloserine will reduce post-traumatic stress disorder symptoms in Iraq war veterans.
Detailed Description
Post-traumatic stress disorder (PTSD) is a type of anxiety disorder affecting people who have witnessed or experienced a traumatic event. Veterans of war are at an increased risk for developing PTSD b...
Eligibility Criteria
Inclusion
- Meets DSM-IV criteria for PTSD due to Iraq military trauma
- Speaks English
- Healthy overall
Exclusion
- History of mania, schizophrenia, or other psychoses
- Suicidal
- Current alcohol or drug dependence
- Medication free within 2 weeks of study entry for any medication that has been taken less than daily for the past month and medicine free within 4 weeks of study entry for any anxiolytic medication that has been taken daily for the last month or more
- Pregnant
- Special medical conditions, such as kidney insufficiency, chronic diseases, or history of significant head injury
- Stabilized on potentially data obscuring medication such as glucocorticoids
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00356278
Start Date
September 1 2006
End Date
June 1 2014
Last Update
January 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30329